Renaissance Technologies (RenTech)'s CCRN Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 245,400 shares of Cross Country Healthcare, Inc. (CCRN) worth $2.31 M, representing 0.00% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 48 quarters.
Based on 13F filings since 2013, Renaissance Technologies (RenTech) has maintained a long-term strategic position in CCRN, representing a significant commitment to this investment thesis. Largest addition occurred in Q4 2022, adding 427,900 shares. Largest reduction occurred in Q2 2023, reducing 353,300 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Cross Country Healthcare (CCRN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Cross Country Healthcare (CCRN) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +30,800 | Add 14.35% | 245,400 | $9.40 |
| Q4 2025 | +11,600 | Add 5.71% | 214,600 | $8.10 |
| Q3 2025 | -85,983 | Reduce 29.75% | 203,000 | $14.20 |
| Q2 2025 | +113,965 | Add 65.12% | 288,983 | $13.05 |
| Q1 2025 | +86,818 | Add 98.43% | 175,018 | $14.89 |
| Q4 2024 | -166,099 | Reduce 65.32% | 88,200 | $18.16 |
| Q3 2024 | +161,790 | Add 174.89% | 254,299 | $13.44 |
| Q2 2024 | +64,091 | Add 225.53% | 92,509 | $13.84 |
| Q1 2024 | +8,632 | Add 43.63% | 28,418 | $18.72 |
| Q4 2023 | -165,044 | Reduce 89.30% | 19,786 | $22.64 |
| Q3 2023 | -65,088 | Reduce 26.04% | 184,830 | $24.79 |
| Q2 2023 | -353,300 | Reduce 58.57% | 249,918 | $0.03 |
| Q1 2023 | +106,300 | Add 21.39% | 603,218 | $0.02 |
| Q4 2022 | +427,900 | Add 619.98% | 496,918 | $0.03 |
| Q3 2022 | +69,018 | New Buy | 69,018 | $28.37 |
| Q2 2022 | -56,618 | Sold Out | 0 | $0.00 |
| Q1 2022 | -110,900 | Reduce 66.20% | 56,618 | $21.67 |
| Q4 2021 | +38,900 | Add 30.24% | 167,518 | $27.76 |
| Q3 2021 | -63,161 | Reduce 32.93% | 128,618 | $21.24 |
| Q2 2021 | +142,661 | Add 290.45% | 191,779 | $16.51 |
| Q1 2021 | -104,700 | Reduce 68.07% | 49,118 | $12.48 |
| Q4 2020 | -57,420 | Reduce 27.18% | 153,818 | $8.87 |
| Q3 2020 | +119,382 | Add 129.97% | 211,238 | $6.49 |
| Q2 2020 | -202,526 | Reduce 68.80% | 91,856 | $6.16 |
| Q1 2020 | -164,548 | Reduce 35.85% | 294,382 | $6.74 |
| Q4 2019 | +226,930 | Add 97.81% | 458,930 | $11.62 |
| Q3 2019 | +156,500 | Add 207.28% | 232,000 | $10.30 |
| Q2 2019 | +53,700 | Add 246.33% | 75,500 | $9.38 |
| Q1 2019 | +8,000 | Add 57.97% | 21,800 | $7.02 |
| Q4 2018 | +13,800 | New Buy | 13,800 | $7.32 |
| Q1 2018 | -12,200 | Sold Out | 0 | $0.00 |
| Q4 2017 | +12,200 | New Buy | 12,200 | $12.79 |
| Q1 2017 | -158,018 | Sold Out | 0 | $0.00 |
| Q4 2016 | +112,101 | Add 244.14% | 158,018 | $15.61 |
| Q3 2016 | -92,401 | Reduce 66.80% | 45,917 | $11.78 |
| Q2 2016 | -196,800 | Reduce 58.73% | 138,318 | $13.92 |
| Q1 2016 | -135,500 | Reduce 28.79% | 335,118 | $11.63 |
| Q4 2015 | +138,400 | Add 41.66% | 470,618 | $16.39 |
| Q3 2015 | +314,318 | Add 1755.97% | 332,218 | $13.61 |
| Q2 2015 | -10,500 | Reduce 36.97% | 17,900 | $12.68 |
| Q1 2015 | -34,300 | Reduce 54.70% | 28,400 | $11.87 |
| Q4 2014 | -89,100 | Reduce 58.70% | 62,700 | $12.47 |
| Q3 2014 | -73,400 | Reduce 32.59% | 151,800 | $9.29 |
| Q2 2014 | -297,402 | Reduce 56.91% | 225,200 | $6.52 |
| Q1 2014 | +238,084 | Add 83.68% | 522,602 | $8.07 |
| Q4 2013 | +219,098 | Add 334.91% | 284,518 | $9.98 |
| Q3 2013 | -30,607 | Reduce 31.87% | 65,420 | $6.04 |
| Q2 2013 | +96,027 | Add 0.00% | 96,027 | $5.15 |
Renaissance Technologies (RenTech)'s Cross Country Healthcare Investment FAQs
Renaissance Technologies (RenTech) first purchased Cross Country Healthcare, Inc. (CCRN) in Q2 2013, acquiring 96,027 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Cross Country Healthcare, Inc. (CCRN) for 48 quarters since Q2 2013.
Renaissance Technologies (RenTech)'s largest addition to Cross Country Healthcare, Inc. (CCRN) was in Q4 2022, adding 496,918 shares worth $13,203.
According to the latest 13F filing for Q1 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 245,400 shares of Cross Country Healthcare, Inc. (CCRN), valued at approximately $2.31 M.
As of the Q1 2026 filing, Cross Country Healthcare, Inc. (CCRN) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Cross Country Healthcare, Inc. (CCRN) was 603,218 shares, as reported at the end of Q1 2023.